Skip to main content
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Font Resize
+A
A
-A
Contrast
عربي
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Home
Search Results
Containing any of the words
Only of the type
All
Annual Report
Conference
Cosmetics Warning
covid pages
Drug evaluation reports
Drug Safety Labeling
Event
Hajj card
hpac-members
Laboratories
List Drugs Withdrawal
Marketed Products
Open Data
Periodic Safety
portables service
Scientific reports and statement
Sector Committee decisions
Standard
Surveys
test
Vaccine Safety
Warehouse
Awareness Article
Awareness Campaign
calculators
Circulars
Clinical Trial
Cosmetics standards Project
Drug Clinical Trial
Drug Log
Drug Membership
Eservices
Events
Excellent establishments list
Forms
HAPC Committee Decisions
head of board
Information List
International Standard
Lists
List of hospital that reported sides effects
List Registered Drugs
List Registered Pharmacies
List Shortage Drug
List Under registration Drugs / Under committee review
Medical devices studies
Medical Report
Message
News
New SFDA Drug Approvals
Podcasts
Reference repositories drugs
Regulations exceptions
Risk Minimization Activity
Risk Minimization Activity - New
Rumours
Safety Alert
Scientific Magazines and articles
sector committee
service providing facilities
Speakers
Standards Projects For Medical Devices
Warnings
EXPERT, EXPosurE Registry RiociguaT in patients with pulmonary hypertension
Drug Clinical Trial
"Tranexamic acid for the treatment of significant traumatic brain injury:an international randomised, double blind placebo controlled trial"
Drug Clinical Trial
"“MERS-CoV Infection Treated with a Combination ofLopinavir/Ritonavir and Interferon Beta 1B: A Placebo-Controlled, Double-BlindRandomized Trial (MIRACLE Trial)”"
Drug Clinical Trial
"SFDA" Hosts the International Regulatory Commission of Herbal Drugs (RCH) Meetings
News
Real World retrospective study of effectiveness and safety of Gilenya (FINgOlimod) in relapsing remitting Multiple Sclerosis in the Middle East and North Africa (FINOMENA)
Drug Clinical Trial
Does the Addition of Proton Pump Inhibitors to Continuous Enteral Feeding Provide Added Protection Against Upper GI Bleeding in Acutely Ill Patients
Drug Clinical Trial
"CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions"
Drug Clinical Trial
A Multicenter, prospective, non-interventional study to assess Adherence to treatment for patIeNts with Relapsing Multiple Sclerosis (RMS) who are prescribed subcutaneous (sc) interferon beta-1a
Drug Clinical Trial
Forxiga (dapagliflozin) Post Authorization Safety Study
Drug Clinical Trial
ChaRactErization of patients following aCute venous thrOmboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the tReatment and secondarY prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice - RE-COVERY DVT/PE
Drug Clinical Trial
Pagination
First page
« First
Previous page
‹ Previous
…
الصفحة
470
الصفحة
471
الصفحة
472
الصفحة
473
Current page
474
الصفحة
475
الصفحة
476
الصفحة
477
الصفحة
478
…
Next page
Next ›
Last page
Last »